Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (13)
Language
- English (13)
Keywords
- COVID-19 (3)
- acute respiratory distress syndrome (2)
- critical care (2)
- inflammation (2)
- oxidative stress (2)
- ARDS (acute respiratory distress syndrome) (1)
- C5aR1 (1)
- Coronavirus Disease 2019 (1)
- Covid-19 (1)
- ECMO (1)
- Germany (1)
- Hamman's syndrome (1)
- Neisseria meningitidis (1)
- SARS-CoV2 (1)
- SUSTAIN CSX (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- acute Respiratory Distress Syndrome (1)
- anaphylatoxins (1)
- cardiac surgery (1)
- cardioprotection (1)
- complement system (1)
- corticoid (1)
- cytokines (1)
- extracorporeal membrane oxygenation (ECMO) (1)
- glutathione peroxidase (1)
- growth differentiation factor 15 (1)
- health care (1)
- immune response (1)
- impedance aggregometry; WHOLE-BLOOD THROMBOELASTOMETRY; DEFINITION; DISEASE (1)
- intensive care medicine (1)
- intensive care unit (1)
- invasive disease (1)
- ischemia/reperfusion injury (1)
- methylprednisolone (1)
- mouse model (1)
- neurological complications (1)
- neutrophils (1)
- nutrient supplementation (1)
- pandemia (1)
- point of care testing (1)
- preconditioning (1)
- public health (1)
- pulse therapy (1)
- quality of life (1)
- salvage therapy (1)
- selen (1)
- selenium (1)
- sepsis (1)
- spontaneous pneumomediastinum (1)
- spontaneous pneumopericardium (1)
- sport medicine (1)
- thromboelastometry (1)
- viral load (1)
- volatile anesthetics (1)
- whole-blood model (1)
- zinc (1)
Institute
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (12)
- Medizinische Klinik und Poliklinik I (4)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Frauenklinik und Poliklinik (2)
- Institut für Hygiene und Mikrobiologie (2)
- Medizinische Klinik und Poliklinik II (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Experimentelle Biomedizin (1)
- Institut für Virologie und Immunbiologie (1)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
Background
Recent data from the randomized SUSTAIN CSX trial could not confirm clinical benefits from perioperative selenium treatment in high-risk cardiac surgery patients. Underlying reasons may involve inadequate biosynthesis of glutathione peroxidase (GPx3), which is a key mediator of selenium's antioxidant effects. This secondary analysis aimed to identify patients with an increase in GPx3 activity following selenium treatment. We hypothesize that these responders might benefit from perioperative selenium treatment.
Methods
Patients were selected based on the availability of selenium biomarker information. Four subgroups were defined according to the patient's baseline status, including those with normal kidney function, reduced kidney function, selenium deficiency, and submaximal GPx3 activity.
Results
Two hundred and forty-four patients were included in this analysis. Overall, higher serum concentrations of selenium, selenoprotein P (SELENOP) and GPx3 were correlated with less organ injury. GPx3 activity at baseline was predictive of 6-month survival (AUC 0.73; p = 0.03). While selenium treatment elevated serum selenium and SELENOP concentrations but not GPx3 activity in the full patient cohort, subgroup analyses revealed that GPx3 activity increased in patients with reduced kidney function, selenium deficiency and low to moderate GPx3 activity. Clinical outcomes did not vary between selenium treatment and placebo in any of these subgroups, though the study was not powered to conclusively detect differences in outcomes.
Conclusions
The identification of GPx3 responders encourages further refined investigations into the treatment effects of selenium in high-risk cardiac surgery patients.